← Leaderboards
Philip C Hopewell
University Of California San Francisco
$14,392,658
Attributed
$15,911,178
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–14$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$15,911,178 · 3
By mechanism
R01$12,874,137 · 2
U01$3,037,041 · 1
Top collaborators
- Walter Boyce5 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Paul R Ortiz De Montellano$16,022,859
- Eric L. Delwart$7,019,880
- Alan D Frankel$24,944,491
- Laura J Esserman$22,971,436
- Norman Hearst$498,684
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisGenotypeTransmission ProcessPharmaceutical PreparationsRisk FactorsInfectionEpidemiologySan FranciscoInvestigationPublic Health Medicine (Field)LaboratoriesBasePreventionOrganismProgramsDesignProspective StudiesIncidenceGenesMolecularCommunitiesMolecular EpidemiologyDisease /Disorder Proneness /Risk
Grant awards (20)
Tuberculosis epidemiology and novel transmission routes in rural Tanzania$597,847
U01 · FY2014 · AI · contact PI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi$654,538
R01 · FY2013 · AI · contact PI
Tuberculosis epidemiology and novel transmission routes in rural Tanzania$563,386
U01 · FY2013 · AI · contact PI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi$721,289
R01 · FY2012 · AI · contact PI
Tuberculosis epidemiology and novel transmission routes in rural Tanzania$599,389
U01 · FY2012 · AI · contact PI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi$733,356
R01 · FY2011 · AI · contact PI
Tuberculosis epidemiology and novel transmission routes in rural Tanzania$611,879
U01 · FY2011 · AI · contact PI
Population Based Molecular epidemiology of Tuberculosis$751,392
R01 · FY2010 · AI · contact PI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi$740,920
R01 · FY2010 · AI · contact PI
Tuberculosis epidemiology and novel transmission routes in rural Tanzania$664,540
U01 · FY2010 · AI · contact PI
Population Based Molecular epidemiology of Tuberculosis$761,225
R01 · FY2009 · AI · contact PI
Effect of Drug Resistance on Transmissibility and Pathogenicity of M. tuberculosi$735,528
R01 · FY2009 · AI · contact PI
Population Based Molecular epidemiology of Tuberculosis$769,038
R01 · FY2008 · AI · contact PI
Population Based Molecular epidemiology of Tuberculosis$796,206
R01 · FY2007 · AI · contact PI
Population Based Molecular Epidemiology of TB$1,192,284
R01 · FY2005 · AI
Population Based Molecular Epidemiology of TB$1,162,560
R01 · FY2004 · AI
Population Based Molecular Epidemiology of TB$1,135,538
R01 · FY2003 · AI
Population Based Molecular Epidemiology of TB$983,370
R01 · FY2002 · AI
Population Based Molecular Epidemiology of TB$993,463
R01 · FY2001 · AI
POPULATION-BASED MOLECULAR EPIDEMIOLOGY OF TUBERCULOSIS$743,430
R01 · FY2000 · AI